Onward Medical N.V. (EBR:ONWD)

Market Cap	229.48M
Revenue (ttm)	2.72M
Net Income (ttm)	-38.65M
Shares Out	44.65M
EPS (ttm)	-0.78
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	187,035
Average Volume	125,101
Open	5.20
Previous Close	5.15
Day's Range	5.14 - 5.38
52-Week Range	3.50 - 7.24
Beta	0.95
RSI	55.24
Earnings Date	Sep 4, 2025

About Onward Medical

Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people with SCI; ARCBCI, an implanted brain-computer interface to restore thought-driven movement. It operates in France, Germany, the Netherlands, the United Ki...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Employees: 103
• Stock Exchange: Euronext Brussels
• Ticker Symbol: ONWD

Financial Performance

In 2024, Onward Medical's revenue was 1.74 million, an increase of 226.88% compared to the previous year's 532,000. Losses were -35.73 million, -1.26% less than in 2023.